AtkinsRéalis Group (ATRL) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
12 Aug, 2026Executive summary
Achieved Q2 revenue of $3.0 billion, up 10% year-over-year, with adjusted EBITDA rising 14% to $293 million and adjusted EPS up 20% to $0.97 per share.
Backlog reached $20.2 billion, with engineering services backlog at a record $13.4 billion and nuclear segment revenue up 18%.
Strategic acquisitions in Australia and Ireland, and continued AI integration to support growth.
Strong nuclear growth, driven by life extension projects, new licensing initiatives, and raised 2026 revenue outlook.
Disciplined capital allocation with share buybacks and robust balance sheet.
Financial highlights
Revenue increased 10% year-over-year to $3.0 billion; organic revenue growth was 8.3%.
Adjusted EBITDA reached $293 million, up 14%, with a margin of 9.8%; adjusted EPS rose 20% to $0.97.
Net cash from operating activities was $84 million; share buybacks totaled $240–245 million for 2.8 million shares.
Net debt ratio remains well below 1x to 2x target, at -0.1.
Backlog as of June 30, 2026, was $20.2 billion, with Engineering Services Regions at a record high.
Outlook and guidance
Raised 2026 nuclear revenue outlook to approximately $2.7 billion (from $2.5 billion).
Engineering Services Regions organic growth expected toward the lower end (5%) of the guidance range due to Middle East conflict.
2027 nuclear revenue guidance remains $2.6–3.0 billion, with expectations to reach the upper half.
Net cash from operating activities forecasted at ~$500 million for 2026; effective tax rate expected between 25–30%.
Latest events from AtkinsRéalis Group
- Revenue up 18% and net income up 34%, driven by strong Nuclear and Engineering Services growth.ATRL
Q1 2026 - Record revenue, earnings, and backlog in 2025 set the stage for continued growth in 2026.ATRL
Q4 2025 - Q3 2025 delivered record revenue, backlog, and margin growth, led by strong Nuclear and Engineering Services gains.ATRL
Q3 2025 - Record revenue, backlog, and nuclear growth highlight a transformative Q2 with major asset sale.ATRL
Q2 2025 - Q3 2024 delivered record Nuclear backlog, margin gains, and robust cash flow generation.ATRL
Q3 2024 - Record backlog, double-digit growth, and upgraded nuclear outlook highlight robust Q2 results.ATRL
Q2 2024 - Targeting >8% organic growth, margin expansion, and nuclear leadership with disciplined capital allocation.ATRL
Investor Day 2024 - Record backlog and surging Nuclear growth drive raised outlook and strong Q1 2025 results.ATRL
Q1 2025 - Record 2024 results, $2.8B asset sale, and strong 2025 growth outlook.ATRL
Q4 2024